Keywords: UK, DDSA Pharma, Amoxycillin, Pricing, Settlement

UK government settles out of court with DDSA Pharma

Article | 24 November 2009

In a joint statement, the UK Department of Health and London-based DDSA Pharmaceuticals said they had agreed an out of court settlement relating to the claims brought against DDSA for an alleged anti-competitive cartel conduct in connection with the supply to the National Health Service of generic drugs.

Under the terms of the settlement DDSA have agreed, on a full and final basis and without admission of liability, to pay the NHS the sum of £120,000 ($198,000) and to provide cooperation in connection with the continuing civil claims regarding the alleged price fixing arrangements. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in